Egr-1 is thought to activate and positively regulate NDRG1 in a variety of cancers; however, in GBM, Egr-1 was not involved in the regulation of NDRG1 expression, indicating that HIF might be the main regulator [59]. The gene discussed is EGR1; the disease is cancer.